يعرض 1 - 10 نتائج من 59 نتيجة بحث عن '"(1"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group

    المؤلفون: Michael Momma, Carmen Loquai, Cristel Ruini, Corinna Kochanek, Kai-Martin Thoms, Selma Ugurel, Carola Berking, Lisa Zimmer, Friedegund Meier, Katharina C. Kähler, Lucie Heinzerling, Dirk Debus, Jessica C. Hassel, Imke Grimmelmann, Claudia Pföhler, Jochen Utikal, Rudolf A. Herbst, Thomas Eigentler, Ralf Gutzmer

    المصدر: European Journal of Cancer. 149:1-10

    مصطلحات موضوعية: Adult, Blood Glucose, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, Medizin, Gastroenterology, Thyroiditis, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Germany, Internal medicine, Diabetes mellitus, medicine, Humans, Lipase, Adverse effect, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Type 1 diabetes, biology, business.industry, Diabetes, Immune checkpoint inhibitors, Immune-related adverse events, Ipilimumab, Nivolumab, Pancreatitis, PD-1 inhibitor, Pembrolizumab, Biomarkers, Diabetes Mellitus, Type 1, Exocrine Pancreatic Insufficiency, Female, Middle Aged, Treatment Outcome, Up-Regulation, medicine.disease, Ketoacidosis, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, Skin cancer, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46f4bea919fbf1345c4e5a2fd89e7ccTest
    https://doi.org/10.1016/j.ejca.2021.02.017Test


    أضف إلى المفضلة
  2. 2
    NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors

    المؤلفون: Michael Weichenthal, Patrick Terheyden, Edgar Dippel, Georg Lodde, Rudolf A. Herbst, Inga Möller, Lisa Zimmer, Dirk Schadendorf, Julia Kretz, Peter Mohr, Ralf Gutzmer, Jochen Utikal, Eleftheria Chorti, Johanna Matull, Claudia Pföhler, Annette Paschen, Luisa Richter, Anne Zaremba, Philipp Jansen, Friedegund Meier, Selma Ugurel, Carl M. Thielmann, Antje Sucker, Eva Hadaschik, Jens Ulrich, Klaus G. Griewank, Alexander Kreuter, Rajmohan Murali, Elisabeth Livingstone

    المصدر: Eur J Cancer

    مصطلحات موضوعية: Adult, Male, Neuroblastoma RAS viral oncogene homolog, congenital, hereditary, and neonatal diseases and abnormalities, Cancer Research, Skin Neoplasms, Adolescent, Immune checkpoint inhibitors, Medizin, Gene mutation, medicine.disease_cause, Article, Young Adult, Humans, Medicine, Immune Checkpoint Inhibitors, Melanoma, neoplasms, Gene, Aged, Aged, 80 and over, Mutation, Neurofibromin 1, business.industry, Middle Aged, medicine.disease, Immune checkpoint, nervous system diseases, Oncology, Cohort, Cancer research, Female, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55018505c8924b71ce959451efd5e004Test
    https://doi.org/10.1016/j.ejca.2021.09.035Test


    أضف إلى المفضلة
  3. 3
    Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study

    المؤلفون: Stéphane Champiat, Christophe Massard, Anne-Laure Voisin, Capucine Baldini, Benjamin Besse, Cedric Pobel, Vincent Thomas de Montpréville, Laurence Albiges, Christina Mateus, Jérôme Le Pavec, Samy Ammari, Aurélien Marabelle, Noémie Chanson, Patricia Pautier, Jean-Marie Michot, Patricia Romano-Martin, Charlotte Cabanié, François-Xavier Danlos, Caroline Even, Olivier Lambotte, Sophie Hans, Emilie Routier, A. Laparra, Celine Boutros, Corinne Balleyguier, Romain David Seban, Samuel Dolidon, Caroline Robert

    المصدر: European Journal of Cancer. 156:46-59

    مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, Sarcoidosis, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Risk Assessment, Severity of Illness Index, Asymptomatic, Young Adult, Risk Factors, Neoplasms, Internal medicine, Humans, Medicine, CTLA-4 Antigen, Registries, Adverse effect, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Granuloma, business.industry, Melanoma, Case-control study, Cancer, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, Oncology, Cohort, Female, medicine.symptom, Tomography, X-Ray Computed, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdee7d15d010644e44ad37349b1f08bTest
    https://doi.org/10.1016/j.ejca.2021.07.015Test


    أضف إلى المفضلة
  4. 4
    Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents

    المؤلفون: Carmen Criscitiello, Antonio Marra, Marta Minotti, Massimo Bellomi, Marzia Locatelli, Carmen Belli, Sara Gandini, Giulia Signorelli, Paola Pricolo, Giuseppe Curigliano, Paolo Tarantino

    المصدر: European Journal of Cancer. 139:92-98

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Neoplasms, Internal medicine, Humans, Medicine, In patient, Lung cancer, Baseline (configuration management), Response Evaluation Criteria in Solid Tumors, Aged, Aged, 80 and over, business.industry, Melanoma, Phase 1 trials, Cancer, Immunotherapy, Middle Aged, medicine.disease, Progression-Free Survival, Immune checkpoint, Tumor Burden, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9fe8d8c9c47eb5aa558fec65dec9a48Test
    https://doi.org/10.1016/j.ejca.2020.08.026Test


    أضف إلى المفضلة
  5. 5
    Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study

    المؤلفون: Sheng Yang, Sheng Yao, Hui Feng, Hai Wu, Yuankai Shi, Haifeng Song, Shiyu Jiang, Zhishang Zhang, Yan Sun, Lihou Dong, Peng Liu, Shuxiang Zhang, Yan Qin, Ying Han, Xiaohong Han, Jiarui Yao, Jianliang Yang

    المصدر: European Journal of Cancer. 130:182-192

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Every Two Weeks, Programmed Cell Death 1 Receptor, Antibodies, Monoclonal, Humanized, Gastroenterology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Refractory, Internal medicine, Alveolar soft part sarcoma, Humans, Medicine, Adverse effect, Aged, business.industry, Standard treatment, Carcinoma, Middle Aged, medicine.disease, Lymphoma, Clinical trial, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, Female, Immunotherapy, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0741fd3644dbba652cb6a6643c09bd74Test
    https://doi.org/10.1016/j.ejca.2020.01.028Test


    أضف إلى المفضلة
  6. 6
    Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

    المؤلفون: Giampiero Porzio, Michele De Tursi, Paolo A. Ascierto, Tea Zeppola, Marcello Tiseo, Daniele Santini, Sebastiano Buti, Francesca Rastelli, Sergio Bracarda, Rossana Berardi, Riccardo Marconcini, Clara Natoli, Andrea De Giglio, Rita Chiari, Cecilia Anesi, Marco Filetti, Federica Zoratto, Rosa Rita Silva, Melissa Bersanelli, Alessio Cortellini, Paolo Marchetti, Raffaele Giusti, Andrea Botticelli, Federica De Galitiis, Alain Gelibter, Corrado Ficorella, Claudia Mosillo, Vito Vanella, Maria Rita Migliorino, Marianna Tudini, Fabiana Perrone, Francesco Atzori, Marco Russano, Biagio Ricciuti, Katia Cannita, Silvia Rinaldi, Domenico Mallardo, Maria Giuseppa Vitale

    المصدر: European Journal of Cancer. 128:17-26

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Programmed Cell Death 1 Receptor, Overweight, Severity of Illness Index, B7-H1 Antigen, Body Mass Index, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Immune-related adverse events, Renal cell carcinoma, Neoplasms, 80 and over, Cancer, Aged, 80 and over, Incidence, Middle Aged, Immunological, BMI, Checkpoint inhibitors, Immunotherapy, Obesity, PD-1/PD-L1, 030220 oncology & carcinogenesis, Female, medicine.symptom, Underweight, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Aged, Humans, Retrospective Studies, Young Adult, Antineoplastic Agents, 03 medical and health sciences, Internal medicine, medicine, Carcinoma, Adverse effect, business.industry, Retrospective cohort study, medicine.disease, 030104 developmental biology, business, Body mass index

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88fb86092cd1e482e67c1ae96e50babTest
    https://doi.org/10.1016/j.ejca.2019.12.031Test


    أضف إلى المفضلة
  7. 7
    Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors

    المؤلفون: Douglas B. Johnson, Javid Moslehi, Joe-Elie Salem, Bénédicte Lebrun-Vignes, Eleonora De Martin, Aurore Vozy

    المصدر: European Journal of Cancer. 123:112-115

    مصطلحات موضوعية: Adult, Male, Cancer Research, Adolescent, Databases, Factual, Immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, MEDLINE, Antibodies, Monoclonal, Humanized, World Health Organization, B7-H1 Antigen, Young Adult, Antineoplastic Agents, Immunological, Neoplasms, medicine, Humans, CTLA-4 Antigen, Young adult, Child, Aged, Aged, 80 and over, Hepatitis, biology, business.industry, Middle Aged, medicine.disease, Ipilimumab, Hepatitis, Autoimmune, Nivolumab, Oncology, Monoclonal, Immunology, biology.protein, Female, Chemical and Drug Induced Liver Injury, Antibody, Massive Hepatic Necrosis, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac204b616f7d2173d4327a89a2f0f0dTest
    https://doi.org/10.1016/j.ejca.2019.09.022Test


    أضف إلى المفضلة
  8. 8
    SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

    المؤلفون: Michael Max Sachse, Florian Kapp, Friedegund Meier, Rose K. C. Moritz, Lisa Zimmer, Katharina C. Kähler, Sebastian Haferkamp, Michael Weichenthal, Sabine Sell, Misbah S. Ahmed, Ralf Gutzmer, Max Schlaak, Julia Welzel

    المصدر: European Journal of Cancer

    مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Cancer Research, Skin Neoplasms, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Programmed Cell Death 1 Receptor, Medizin, Risk Assessment, German, Risk Factors, Internal medicine, Germany, medicine, Humans, Registries, Letter to the Editor, Immune Checkpoint Inhibitors, Melanoma, Aged, Aged, 80 and over, business.industry, COVID-19, Middle Aged, medicine.disease, Prognosis, language.human_language, language, Female, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7523296efab65101793a258568235614Test


    أضف إلى المفضلة
  9. 9
    Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

    المؤلفون: Thomas Eigentler, Cindy Franklin, Anja Gesierich, Claus Garbe, Sebastian Haferkamp, James Larkin, Sophia Kreft, Paul Lorigan, Bastian Schilling, Sara Valpione, Selma Ugurel, Jochen Utikal, Dirk Schadendorf, Christian U. Blank

    المصدر: European Journal of Cancer. 116:207-215

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Targeted therapy, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Adverse effect, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Salvage Therapy, business.industry, Immunotherapy, Middle Aged, medicine.disease, Confidence interval, Nivolumab, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0f33bef3ecdaf233f4184cbdb0bbc1eTest
    https://doi.org/10.1016/j.ejca.2019.05.015Test


    أضف إلى المفضلة
  10. 10
    Immune checkpoint inhibitor–associated hypophysitis—World Health Organisation VigiBase report analysis

    المؤلفون: Elisa Guerrero, Anne Bachelot, Bénédicte Lebrun-Vignes, Douglas B. Johnson, Javid Moslehi, Joe-Elie Salem

    المساهمون: Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Service de pharmacologie médicale [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CIC Paris Est, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Régional de Pharmacovigilance (CRPV), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)

    المصدر: European Journal of Cancer
    European Journal of Cancer, Elsevier, 2019, 113, pp.10-13. ⟨10.1016/j.ejca.2019.03.002⟩

    مصطلحات موضوعية: Adult, Male, Cancer Research, Databases, Factual, Hypophysitis, [SDV]Life Sciences [q-bio], Immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, MEDLINE, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, World Health Organization, B7-H1 Antigen, World health, Pharmacovigilance, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, medicine, Humans, CTLA-4 Antigen, Young adult, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, biology, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Ipilimumab, 3. Good health, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Monoclonal, Immunology, biology.protein, Female, Antibody, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2adb80495d7a32fa09cbe58190fb5710Test
    https://doi.org/10.1016/j.ejca.2019.03.002Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث